✦ LIBER ✦

A regulatory perspective on the abuse potential evaluation of novel stimulant drugs in the United States

✍ Scribed by Calderon, Silvia N.; Klein, Michael

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacogenetics in the evaluation of ne

✍ Maliepaard, Marc; Nofziger, Charity; Papaluca, Marisa; Zineh, Issam; Uyama, Yosh 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 461 KB

Current regulatory toxicology perspectiv

✍ Kuei-Meng Wu; Hanan Ghantous; Debra B. Birnkrant 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Regulatory Perspectives on Pharmacogenom

✍ Phillips, K. A. 📂 Article 📅 2006 🏛 SAGE Publications 🌐 English ⚖ 149 KB

Costs of prescription opioid analgesic a

✍ H.G. Birnbaum; J. Reynolds; G. Jetley; M. Zhang; S. Vallow 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Drug Crime Is a Source of Abused Pain Me

✍ David E. Joranson; Aaron M. Gilson 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 60 KB

A synthesis review of exemplary drug abu

✍ Ken C. Winters; Tanya Fawkes; Tamara Fahnhorst; Andria Botzet; Gerald August 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 165 KB